Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28 |
filingDate |
2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e62c09846bf74ece0418922ee07cc5be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2a427e78e4d6e10d8c167726e00cb9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20b4cc7c75543a57ca048609ad2d8bcf |
publicationDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017132158-A1 |
titleOfInvention |
Crystalline form of 1,3-thiazol-5-ylmethyl [(2r,5r)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl 9amino}-1,6-diphenylhexan-2-yl]carbamate or cobicistat |
abstract |
The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039718-B2 |
priorityDate |
2016-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |